TRACHEOSTOMY MARKET REPORT OVERVIEW
- Request a Free sample to learn more about this report
The global tracheostomy market size was expected to be USD 186 million in 2021 and the market is projected to touch USD 242.2 million by 2028, with a growing CAGR of 3.8% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels.
It is a surgical operation that involves making an incision (cut) on the front of the neck and providing a direct airway through an incision in the trachea (windpipe). The resulting stoma (hole) can function as an airway on its own or as a location for the insertion of a tracheal tube or tracheostomy tube, which allows a person to breathe without using their nose or mouth. A tracheotomy may be performed for one of four reasons: Access to an emergency airway, airway access for prolonged mechanical breathing, functional or mechanical upper airway obstruction, and decreased/incompetent clearance of tracheobronchial secretions are all symptoms of tracheobronchial secretions.
COVID-19 Impact: Pandemic Effectuated the Emphasize on the Product and Upsurge the Demand
According to the World Health Organization's June 2020 report, noncommunicable disease (NCD) prevention and treatment services have been severely disrupted since the onset of the COVID-19 epidemic. However, as COVID incidence decreased, surgical operations related with numerous diseases began to accelerate. A group of Mount Sinai doctors in New York, for example, performed the nation's 1st human tracheal transplant in April 2021. Thousands of people with acute tracheal damages from intubation, tracheal birth defects, incurable airway problems, burns, tumours, and COVID-19 hospitalizations may be rescued as a result of this accomplishment. As a result, COVID-19 first hampered the expansion of the tracheostomy business, but the market began to gain pace as the situation stabilized.
LATEST TRENDS
"Technological Advancements to Inflate the Market Demand"
Advanced technologies and more product approvals, as well as partnerships and collaborations by key players, are assisting in market expansion. Smiths Medical, for example, introduced portex, a new Polyvinyl Chloride (PVC) tube portfolio to their line of tracheostomy tubes, in January 2020. The launches relating to tubes are expected to boost segment growth.
TRACHEOSTOMY MARKET SEGMENTATION
- Request a Free sample to learn more about this report
- By Type
Based on type; the tracheostomy market is divided into PVC tube, silicone rubber tube and others.
PVC tube is the leading part of the type segment.
- By Application
Based on the application; the tracheostomy market is divided into emergency treatment, therapy and others.
Therapy is the leading part of the application segment.
DRIVING FACTORS
"The Application of the Tracheostomy Tube to Advance the Market Share"
Tracheostomy tubes are used in treatments for obstructive sleep apnea, coma, chronic lung illness, diaphragm malfunction, anaphylaxis, throat cancer, laryngectomy, and vocal cord paralysis, among other causes. The major benefits provided, such as risk of aspiration, avoidance of numerous laryngoscopies, high accuracy, reduced air pollution and enhanced ventilation and correct tidal volume, intubations, and end-tidal carbon dioxide monitoring, can be linked to the tubes segment's rapid rise. It is a surgical procedure used to treat obstructive sleep apnea (OSA). The high burden of OSA is likely to augment the demand for tracheostomy market for tubes.
"The Intensive Use in Treating Cancer Patients to Drive the Market Growth"
Tracheostomy market would grow at a modest pace due to factors such as high demand for throat cancer treatment in different provinces, the expansion of cancer care facilities in developing countries, growing adoption for advanced cancer therapies, and increased federal funding in the healthcare sector. Tracheostomies are also commonly used to treat patients with head and neck cancers such as tongue cancer, mouth cancer, and thyroid cancer. In 2020, there were more than 2.2 million new instances of lung cancer, in accordance with the World Cancer Research Fund International 2022 report. Lip and oral cavity cancers are the most common, with about 377,700 reported cases in the world in 2020.
RESTRAINING FACTORS
"The Complications and Risk Associated with the Treatment to Restrain the Market"
Some cases, like most other surgical operations, are more complex than others. Children's surgery is more difficult due to their tiny size. Difficulties such as a short neck and larger thyroid glands make it difficult to expand the trachea. Other issues arise with patients who have uneven necks, are fat, or have a huge goitre. Hemorrhage, airway obstruction, subcutaneous emphysema, wound infections, stomal cellulites, fracture of tracheal rings, improper placement of the tracheostomy tube, and bronchospasm are all possible problems. Hemorrhage, tracheoesophageal fistula, pneumothorax, pneumomediastinum, recurrent laryngeal nerve damage, and tube displacement are examples of early problems. Tracheal-innominate artery fistula, delayed tracheoesophageal fistula, tracheal stenosis and tracheocutaneous fistula are examples of delayed complications.
TRACHEOSTOMY MARKET REGIONAL INSIGHTS
- Request a Free sample to learn more about this report
"North America to Lead the Market with Presence of Developed Healthcare System"
North America is one of the market's most profitable regions. The presence of a well-developed healthcare system, an increase in emergency department visits, widespread adoption and availability of product innovations among medical professionals, a large number of established device manufacturing companies, and the surging rates of chronic pulmonary are fuelling the expansion of the product lines industry in North America. Furthermore, favourable government efforts and an expansion in research & development activities are likely to fuel market expansion. Amylyx Pharmaceuticals, for example, reported the results of the Phase 2 CENTAUR trial, which included tracheostomy, permanent assisted ventilation (PAV), and the first hospitalisation, in May 2022. The indulgence of major key market players in the clinical trials and research activities related to tracheostomy market share is expected to augment the tracheostomy market growth in the region.
KEY INDUSTRY PLAYERS
"Key Industry Players to Promote the Market Expansion"
The market's expansion was significantly impacted by the techniques employed by market participants in recent years, such as extensions. The report covers details and information about the firms and their interactions with the market. The data is gathered and published through appropriate research, technological advancements, expansions, and expanding machinery and equipment. Other considerations taken into account for this market are the businesses that develop and provide new products, the geographic areas in which they function, mechanization, innovation strategies, generating the maximum revenue, and using their products to make a significant difference.
List of Market Players Profiled
- Medtronic plc (Ireland)
- Smiths Group plc (U.K.)
- TRACOE Medical GmbH (Germany)
- Teleflex Incorporated (U.S.A)
- Fisher & Paykel Healthcare Ltd. (New Zealand)
- ConvaTec Group (U.S.A)
- Cook Group (U.S.A)
- Troge Medical GmbH (Germany)
- Well Lead Medical Co., Ltd. (U.S.A)
- Fuji Systems Corporation (Japan)
- Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany)
- Xinxiang Huaxi Sanitary Materials Co., Ltd. (China)
- Medis Medical (Tianjin) Co. Ltd. (China)
- Boston Medical (U.S.A)
- Pulmodyne (U.S.A).
REPORT COVERAGE
This report covers a comprehensive backdrop analysis, an assessment of the parent market, intensive study in the market dynamics. Past historical, current, and projected size of the market from the point of both value and volume. Researching of recent industry developments, deep study on market shares and strategies of major players and the emerging niche segments and regional market areas are covered in the report.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 186 Million in 2021 |
Market Size Value By |
US$ 242.2 Million by 2028 |
Growth Rate |
CAGR of 3.8% from 2021 to 2028 |
Forecast Period |
2022-2028 |
Base Year |
2022 |
Historical Data Available |
Yes |
Segments Covered |
Types & Application |
Regional Scope |
Global |
Frequently Asked Questions
-
1. What value is the tracheostomy market expected to touch by 2028?
Based on our research, the global tracheostomy market is projected to touch USD 242.2 million by 2028.
-
2. What CAGR is the tracheostomy market expected to exhibit by 2028?
The tracheostomy market is expected to exhibit a CAGR of 3.8% by the forecasted year 2028.
-
3. What are the driving factors of the tracheostomy market?
The application of the tracheostomy tube and the intensive use in treating the cancer patients are the driving factors of the tracheostomy market.
-
4. Which are the top companies operating in the tracheostomy market?
Medtronic, Teleflex Medical, Smiths Medical, TRACOE Medical, ConvaTec, Boston Medical, Cook Inc, Fuji Systems, Pulmodyne, Well Lead, TuoRen and others.